| 000 | 01105nam a2200277Ia 4500 | ||
|---|---|---|---|
| 001 | 88557 | ||
| 003 | BIBL | ||
| 005 | 20160527204313.0 | ||
| 008 | 720428s1964 dcua b 100 0 eng | ||
| 010 | _a 64022278 | ||
| 035 | _a(OCoLC)00296290 | ||
| 040 |
_aDLC _cCSU _dOCL _dCHS _dOCL _dm.c. |
||
| 049 | _aPUXA | ||
| 050 | 0 |
_aQD1 _b.A355 no. 45 |
|
| 082 | _a615.19 | ||
| 096 | _aQV 34 A512m 1964 | ||
| 245 | 0 | 0 |
_aMolecular modification in drug design _ba symposium sponsored by the Division of Medicinal Chemistry at the 145th meeting of the American Chemical Society, New York, N.Y., Sept. 9-10, 1963. _cFred W. Schueler, symposium chairman. |
| 260 | 0 |
_aWashington _bAmerican Chemical Society _c1964. |
|
| 300 |
_avii, 228 p. _billus. _c24 cm. |
||
| 490 | 0 |
_aAdvances in chemistry series _v45 _949468 _2Local |
|
| 504 | _aIncludes bibliographies. | ||
| 650 | 0 |
_aPharmaceutical chemistry. _xCongresses. _9150474 _2Local |
|
| 650 | 2 |
_aDrug Therapy _988810 _2Local |
|
| 650 | 2 |
_aChemistry, Pharmaceutical _972306 _2Local |
|
| 710 | 2 | 0 |
_aAmerican Chemical Society. _bDivision of Medicinal Chemistry. _wcn _952046 _2Local |
| 999 |
_c72013 _d72013 |
||